Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advices EQT VIII in connection with the acquisition of Recover Nordic
Mandate

Vinge advises EQT VIII in connection with the acquisition of Recover Nordic

December 10, 2019 M&A

Vinge has advised EQT VIII in connection with the acquisition of Recover Nordic from funds advised by Agilitas Private Equity.

Recover Nordic is a Nordic market leader in property remediation and environmental services, primarily serving insurance companies, municipalities, industrial- and commercial clients. Headquartered in Oslo, Norway and with more than 90 branches across the Nordics, the Company has over 2,100 employees and is expected to generate revenues of NOK 3.0 billion in 2019.

The transaction is expected to close in the first quarter of 2020.

Vinge’s team consisted of Daniel Rosvall, Johanna Wiberg, Christian Brelin and Ellinor Wargenbrant (M&A), Johan Cederblad and Cornelia Medrek (Environment), Josefine Lanker and Axel Jansson (Banking and Financing), Mathilda Persson, Rebecka Maltenius, Martin Boström and Lisa Hörnqvist (Commercial Agreements and IT), Emma Johansson (Competition and Regulatory), Lisa Ullman and Ebba Svenburg (Employment) and Kristoffer Larson (Real Property).

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

 Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026